Enregistrement :
10
de
12
(2013-12-02
à
2015-04-30)
Politique ou Programme
Canadian Agency for Drugs and Technologies in Health policies with respect to the Common Drug Review, Health Technology Assessment and the Canadian Optimal Medication Prescribing and Utilization Service
Federal Health Partnership with respect to the coordination of federal drug plan policies and programs
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Industry Canada policies related to research and development of treatments for rare disorders
International Trade Canada's Invest in Canada policies and programs with respect to investment, business development and innovation in the life sciences industry sector
Orphan drug policy to address treatment for rare disorders
Patented Medicines Prices Review Board with respect to excessive price guidelines
Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Proposition législative, Projet de loi ou résolution
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products and legislative modernization
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
Proposition législative, Projet de loi ou résolution, Règlement
Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with respect to therapeutic products and consumer products
Règlement
Food and Drug Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products and Data Protection under section C.08.004
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically proposed amendments to the Patented Medicines (Notice of Compliance) Regulations.
Patent Act Regulations with respect to Patented Medicines (Notice of Compliance) Regulations
Patent Act as it relates to the regulation of intellectual property for therapeutic products